A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

Name: A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
Published: 2025
License: Public Domain

ModernaTX, Inc. · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

coronavirus coronavirus-infections sars-cov-2

covid-19, mrna-1283, mrna-1283 vaccine, sars-cov-2, sars-cov-2 vaccine, coronavirus, coronavirus infections, virus diseases, mnexspike®, covid-19 vaccine, moderna, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

Related documents